Groups | PBS s.c. | OVA s.c. | PBS i.p. | CO i.p. | NA i.p. | ETX i.n. |
PBS/CO | + | - | - | + | - | - |
PBS/NA | + | - | - | + | + | - |
OVA/CO | - | + | - | + | - | - |
OVA/NA | - | + | - | + | + | - |
PBS/PBS | + | - | + | - | - | - |
PBS/OVA | - | + | + | - | - | - |
OVA/CO/ETX | - | + | - | + | - | + |
OVA/NA/ETX | - | + | - | + | + | + |
Groups included mice that were either sham-sensitised with PBS or ovalbumin (OVA)-sensitised, and treated with solvent corn oil (CO) only or with naphthalene (NA) dissolved in CO. Additional groups included OVA-sensitised, CO- or NA-treated mice that received a single dose of intranasal eotaxin (ETX; 4 μg) on the first day of challenge. s.c.: subcutaneous; i.p.: intraperitoneal; i.n.: intranasal. +: treated with; -: excluded.